7-Ethyl-10-hydroxycamptothecin
Intermediate
IntermediateConfidentiality：Public
- INN / Generic Name
- 7-Ethyl-10-hydroxycamptothecin
- CAS No.
- 86639-52-3
- Current Status
- Official intermediate catalog (API: Irinotecan hydrochloride)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
Formulation & registration fields (API/FDF oriented — tap to expand)
- Dosage Form
- —
- Strength
- —
- Therapy Area
- Pharmaceutical Intermediates
- Indication
- API: Irinotecan hydrochloride
- GMP Certification
- —
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- FSO supply (non-registered substance)
HS Code
29349990992706 customs bills on file
Registrable Markets
Global
Process / Sequence / Exact Price
- Process Summary
- Intermediate #1 of Route 1 (7 steps) for Firtecan pegol. Route materials include: (S)-9-((tert-butyldiphenylsilyl)oxy)-4,11-diethyl-4-hydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione, 2-((tert-butoxycarbonyl)amino)acetic acid, (S)-9-((tert-butyldiphenylsilyl)oxy)-4,11-diethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl (tert-butoxycarbonyl)glycinate, (S)-9-((tert-butyldiphenylsilyl)oxy)-4,11-diethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl glycinate hydrochloride, tert-butyl 2-bromoacetate, 7,7'-(oxybis(methylene))bis(3,6,9,12-tetraoxatetradecanedioic acid), tetrakis((S)-9-((tert-butyldiphenylsilyl)oxy)-4,11-diethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl) 10,10'-(oxybis(methylene))bis(4,17-dioxo-6,9,12,15-tetraoxa-3,18-diazaicosanedioate), 2,2',2'',2'''-((oxybis(propane-3,1,2-triyl))tetrakis(oxy))tetrakis(ethan-1-ol). Source: Pharmacodia route data (in-house patent-cliff DB); full step sequence via SciFinder / Google Patents.Synthesis route auto-filled from in-house Pharmacodia route data — verify full steps on SciFinder / Google Patents.
- Exact Price